Submission Details
| 510(k) Number | K181823 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 09, 2018 |
| Decision Date | March 11, 2019 |
| Days to Decision | 245 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K181823 is an FDA 510(k) clearance for the KardiaAI, a Computer, Diagnostic, Programmable (Class II — Special Controls, product code DQK), submitted by AliveCor, Inc. (Mountain View, US). The FDA issued a Cleared decision on March 11, 2019, 245 days after receiving the submission on July 9, 2018. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1425.
| 510(k) Number | K181823 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 09, 2018 |
| Decision Date | March 11, 2019 |
| Days to Decision | 245 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQK — Computer, Diagnostic, Programmable |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1425 |